Skip to main content
Equibles

OGI · Organigram Global Inc.

Track OGI — free

Use OGI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OGI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.94 -0.02 (-1.69%) At close · Oct 5
Rebalance outlook locked
Market Cap
$155.11M
Shares
141.01M
Volume · Oct 5 674.4K Avg daily vol (3M) 871.2K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.94 Open$0.96 Day$0.92–0.96 52W close$0.87–2.11 Avg vol 30d544K Short int4.9M · 3.5% float · 9.5d Short vol31% Last earningsAug 11, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Dec 1, 2026 Est · unconfirmed · in 8 wks
Q3 2026 earnings call transcript
call held Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-49.0%
Trailing year
Short interest
3.5%
Latest settlement · 9.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg −15%
below
RSI (14) 28
oversold
MACD trend Negative
52-week position 5%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −19%
trailing
6-month return −34%
trailing
YTD return −44%
this year
Relative strength −46%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.46% of float · ▼ -10.6% MoM · 9.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
68 holders — mid 1-yr range
Squeeze score 47
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 58%
annualized · 1-yr
Max drawdown −59%
past year
ATR 5.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 11, 2026
Revenue · full year of fiscal 2026 Initiated at least $350M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
28 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.46% of float · ▼ -10.6% MoM · 9.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
68 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 5% Range high $2
vs 200-day avg -27% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OGI
Organigram Global Inc.
this stock
$155.11M -44.2% — — 3.5%
TAK
Takeda Pharmaceutical Co Ltd
 $60.23B +14.2% — — 0.1%
GALDY
Galderma Group AG/ADR
 $46.00B -6.1% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.67B +27.1% +4.3% 64.3 2.7%
HLN
Haleon plc
 $40.72B -12.8% — — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
68
% held
5.5%
Net QoQ
-409.1K sh
Top holder
Tidal Investments LLC
Held Float
View
Held by Funds
Fund positions
15
View
Short & Settlement
Short Interest Falling
Shares short
4.9M
Days to cover
9.5d
Change
-577.3K sh
View
Short Volume
Short vol %
31%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
13.7K
Value
$14.4K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
62.5%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 30, 2026
This year
24
View
Exempt Offerings
Offering
$175.0M
Filed
Mar 25, 2021
View
Earnings & Events
Webcasts
Last webcast
Aug 11, 2026
View

Performance

5D 20D 120D MTD YTD
OGI -13.6% -18.9% -34.5% -5.9% -44.2%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -14.8% -19.5% -46.1% -7.5% -57.9%
Key facts CIK 1620737 CUSIP 68617J100 Visit website Investor relations